BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors

NCT01297452 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: BKM120 days 1 - 21 plus paclitaxel + carboplatin
DRUG: BKM120 (days 1 - 28, ) plus paclitaxel + carboplatin
DRUG: BKM120 (days 1-21) + paclitaxel (day 1) + carboplatin (day 1)
DRUG: BKM120, Paclitaxel + Carboplatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]